{name}
{subtitle}
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
city
~91 mi. (Pereira, Colombia, +144 more cities)
facility
Oncólogos del Occidente S.A ( Site 0501)
drug
belzutifan, +3 more drugs
drug type
immunotherapy, +1 more type
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
city
~91 mi. (Pereira, Colombia, +150 more cities)
facility
Oncologos del Occidente S.A. ( Site 0310)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +2 more types
Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)
city
~91 mi. (Pereira, Colombia, +137 more cities)
facility
Oncologos del Occidente S.A. ( Site 0206)
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
city
~91 mi. (Pereira, Colombia, +142 more cities)
facility
Oncologos del Occidente S.A
biomarker
del(11)(q10), +27 more biomarkers
drug
imetelstat, +1 more drug